Biorex Inc.

International Private company
295 Ch Sainte-Foy, Quebec, QC G1R 1T5, Canada
(418)5224945, (418)5225218 fax, http://www.biorex.com

Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Environmental consultants offering environmental impact studies, evaluation of land and water resources, utilization of under utilized biomass fisheries, biochemical analysis, research and development in fisheries and aquaculture, and other studies related to wildlife resources.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Biorex Inc., News and Information

SLXP, CBB, SAH, PNX, FUN and BBND Expected To Be Lower After Earnings Releases on Tuesday.
M2 Presswire; 5/4/2009; 3464 words; ...Before SAH Sonic Automotive, Inc. 6 quarters Q1 Before PNX The...Before BBND BigBand Networks, Inc. 12 quarters Q1 After Earnings...Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars...GmbH; King Pharmaceuticals, Inc.; Merck & Co., Inc...

CytRx Forming Subsidiary To Accelerate RNAi Work.(ribonucleic acid interference)
BIOWORLD Today; 1/31/2006; 1535 words; ...Mass.-based Alnylam Pharmaceuticals Inc., which has a market cap of $333 million...which it acquired when it bought out Biorex Research & Development RT, of Veszprem...preclinical work. Two other drugs acquired from Biorex are iroxanadine for diabetes and cardiovascular...

OTHER NEWS TO NOTE.(biotechnology indutries)
BIOWORLD Today; 1/12/2005; 2503 words; ...therapeutics. Cryo-Cell International Inc., of Oldsmar, Fla., supported...reduction in heart damage. Curis Inc., of Cambridge, Mass., said...results, which were generated by Biorex Research and Development Co...based Merck & Co. Inc. on development of therapeutic...

RNAi company reports reduced losses in Q3.
Obesity, Fitness & Wellness Week; 12/18/2004; 935 words; ...and pharmaceutical assets of Biorex Research & Development...2004. As a result of the Biorex transaction, CytRx has taken...therapeutics company. "The Biorex assets that we acquired include...licensing agreement with SynthRx, Inc., for FLOCOR and other related...

CytRx Corporation Reports Third Quarter 2004 Financial Results.
PR Newswire; 11/9/2004; 2614 words; ...and pharmaceutical assets of Biorex Research & Development...2004. As a result of the Biorex transaction, CytRx has taken...major therapeutics company. The Biorex assets that we acquired include...licensing agreement with SynthRx, Inc. for FLOCOR(TM) and other...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.